Opportunity Information: Apply for PAR 18 833
The National Institute of Mental Health (NIMH), through its Division of AIDS Research (DAR), is soliciting applications for Developmental AIDS Research Centers (D-ARC) using the NIH P30 Center Core Grant mechanism under funding opportunity PAR-18-833. The central purpose of this program is to build and strengthen shared research infrastructure that helps investigators generate high-impact, mission-relevant science at the intersection of HIV/AIDS and mental health. Rather than primarily paying for one stand-alone research project, a P30 D-ARC is meant to create the kind of institutional backbone that makes multiple HIV and mental health studies possible, stronger, and more competitive over time.
The scope is intentionally broad and interdisciplinary, reflecting the many ways mental health and HIV influence each other across biological, clinical, and community contexts. NIMH highlights interest in innovative research spanning basic science, neurological research including neuro-HIV, behavioral and social science, integrated biobehavioral approaches, applied and clinical research, translational science, and implementation science. In practical terms, the Center is expected to support and accelerate research that can move from foundational mechanisms to real-world interventions, including work focused on improving prevention, care engagement, treatment outcomes, and mental health functioning among people affected by HIV.
Because this is a Center Core (P30) program, the emphasis is on creating shared resources, services, and coordinated supports that can be used by multiple investigators. Typical P30 structures in NIH programs often involve administrative leadership and a set of scientific cores (for example, methods, clinical support, biostatistics, data management, behavioral assessment, neuroimaging, community engagement, or implementation support), along with developmental components that help launch new lines of research. The word "Developmental" in D-ARC signals a strong interest in growing capacity: helping early-stage or new-to-HIV investigators, fostering new collaborations, piloting innovative ideas, and positioning the institution to compete for larger, independent research grants in the future. The "Clinical Trial Optional" designation indicates that clinical trials may be included if they fit the Center's goals, but they are not required.
Eligibility is broad and includes many types of U.S.-based organizations: state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other organizations that meet NIH eligibility rules. The FOA also calls out additional eligible applicants such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments that are not federally recognized, and U.S. territories or possessions.
Foreign eligibility is limited in a way that is common for NIH center programs. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply as the main applicant organization. However, "foreign components" are allowed as defined by the NIH Grants Policy Statement, meaning a U.S. applicant may include certain well-justified international collaborations or activities as part of the proposed work when they are necessary to accomplish the project goals and meet NIH policy requirements.
From the funding details provided, the opportunity falls under the NIH health research assistance listing (CFDA 93.242) and is categorized as a discretionary grant. The listed award ceiling is $750,000, indicating the upper limit for annual direct costs or total costs as specified in the FOA (applicants would need to confirm the exact interpretation in the full announcement). The original closing date shown is September 11, 2020, and the opportunity was created on June 15, 2018, which suggests the posted cycle is historic; anyone interested in pursuing this type of funding would want to check NIH for the most current, active reissue or successor announcement and associated due dates.
Overall, this FOA is aimed at institutions that want to build a durable, cross-disciplinary HIV and mental health research ecosystem. A competitive application would typically demonstrate a compelling scientific vision aligned with NIMH priorities, a clear plan for cores and shared services that fill real institutional gaps, strong leadership and governance, strategies to support and develop investigators and new projects, and a credible path to producing high-impact outputs and future independent NIH funding in HIV/AIDS and mental health research.Apply for PAR 18 833
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2018-06-15.
- Applicants must submit their applications by 2020-09-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $750,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Request for Information (RFI) Rule of Law (ROL) USAID/Mexico
Previous opportunity: FY 2018 National Infrastructure Investments
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 833
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 833) also looked into and applied for these:
| Funding Opportunity |
|---|
| AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) Apply for PAR 18 832 Funding Number: PAR 18 832 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed) Apply for RFA AI 18 026 Funding Number: RFA AI 18 026 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed) Apply for RFA AG 19 016 Funding Number: RFA AG 19 016 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed) Apply for RFA AG 19 015 Funding Number: RFA AG 19 015 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) Apply for PAR 18 840 Funding Number: PAR 18 840 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required) Apply for RFA AI 18 022 Funding Number: RFA AI 18 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21 Clinical Trial Not Allowed) Apply for RFA AI 18 025 Funding Number: RFA AI 18 025 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) Apply for PAR 18 844 Funding Number: PAR 18 844 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) Apply for PAR 18 843 Funding Number: PAR 18 843 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 037 Funding Number: RFA AI 18 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional) Apply for RFA DC 19 001 Funding Number: RFA DC 19 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Required) Apply for RFA MH 19 101 Funding Number: RFA MH 19 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Not Allowed) Apply for RFA MH 19 100 Funding Number: RFA MH 19 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The National Health and Aging Trends Study (U01 Clinical Trial Not Allowed) Apply for RFA AG 19 019 Funding Number: RFA AG 19 019 Agency: National Institutes of Health Category: Health Funding Amount: $550,000 |
| NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional) Apply for PA 18 851 Funding Number: PA 18 851 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry (U24 Clinical Trial Not Allowed) Apply for RFA DC 19 002 Funding Number: RFA DC 19 002 Agency: National Institutes of Health Category: Health Funding Amount: $425,000 |
| Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required) Apply for RFA AI 18 036 Funding Number: RFA AI 18 036 Agency: National Institutes of Health Category: Health Funding Amount: $10,000,000 |
| Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA DE 19 004 Funding Number: RFA DE 19 004 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Cooperative Agreement to Support Navigators in Federally-facilitated Exchanges Apply for CA NAV 18 001 Funding Number: CA NAV 18 001 Agency: CMS-Consumer Information Insurance Oversight Category: Health Funding Amount: Case Dependent |
| Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) Apply for PA 18 859 Funding Number: PA 18 859 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 833", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
